MEDROXYPROGESTERONE ACETATE
NDC 62756-091, MEDROXYPROGESTERONE ACETATE, injection, suspension, from Sun Pharmaceutical Industries, Inc..
- Product NDC
- 62756-091
- Status
- Listed
- Labeler
- Sun Pharmaceutical Industries, Inc.
- Dosage form
- INJECTION, SUSPENSION
- Route
- INTRAMUSCULAR
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA210761
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/62756-091 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- MEDROXYPROGESTERONE ACETATE150 mg/mL
Pharmacologic classes
Progesterone Congeners [CS]; Progestin [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 62756-091-40 | 62756009140 | 1 SYRINGE in 1 CARTON (62756-091-40) / 1 mL in 1 SYRINGE |
Linked data
RxNorm, label and prices
Related lookups
FDA label sections
GET /v1/drugs/labels/01e28bef-9758-40cf-a4ff-86ae9f4f5105
Use it
Look up 62756-091 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/62756-091 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 62756-091. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.